PharmaCyte Biotech Inc (PMCB)

[Triple9]

In my opinion, these changes were made at the request of a future partner and provide guarantees that the underlying technology can't be bought from Astronova while we are in clinical trials.

It also expands the use of CiaB with any and all cell lines, including TCells.

Interesting, positive development.

Confidentiality Austrianova and PharmaCyte each agree that neither it, nor its respective subsidiaries, affiliates, employees or
representatives will disclose any information of the other party that is deemed confidential, including, without limitation,
the existence of this Term Sheet or the terms and conditions contained herein, except on a reasonable need to know basis.
Notwithstanding the foregoing, the parties expressly acknowledge that PharmaCyte may file a copy and/or a description
of, this Term Sheet with the United States Securities and Exchange Commission (“ SEC ”) in any of its SEC reports and
filings, as well as incorporate them by reference into other SEC filings to the extent required by law.